Breaking News Instant updates and real-time market news.

WTRE

Watford Holdings

$17.45 /

+0.23 (+1.34%)

16:58
07/29/20
07/29
16:58
07/29/20
16:58

Watford Holdings reports Q2 EPS $9.51, two estimates $6.79

Combined ratio of 108.0%, comprised of a 79.7% loss ratio, a 22.4% acquisition expense ratio and a 5.9% general and administrative expense ratio, compared to a combined ratio of 103.5% for the prior year second quarter, comprised of a 73.6% loss ratio, a 23.4% acquisition expense ratio and a 6.5% general and administrative expense ratio; Book value per diluted common share was $38.82 at June 30, 2020, an increase of 37.6% from March 31, 2020. The company said: "Following the first quarter of 2020, the novel coronavirus pandemic has continued to cause unprecedented economic volatility and disruption globally. At this time, there continues to be significant uncertainties surrounding the ultimate number of insurance claims and scope of damage resulting from this pandemic."

  • 30

    Jul

WTRE Watford Holdings
$17.45 /

+0.23 (+1.34%)

11/06/19
Fly Intel: Top five analyst initiations
11/06/19 Morgan Stanley
Watford Holdings initiated with an Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

Recommendations
ZoomInfo price target lowered to $60 from $64 at RBC Capital » 06:23
06/15/21
06/15
06:23
06/15/21
06:23
ZI

ZoomInfo

$46.35 /

-0.1 (-0.22%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZI ZoomInfo
$46.35 /

-0.1 (-0.22%)

ZI ZoomInfo
$46.35 /

-0.1 (-0.22%)

05/04/21 Truist
ZoomInfo price target raised to $70 from $67 at Truist
05/04/21 Deutsche Bank
ZoomInfo price target lowered to $54 from $58 at Deutsche Bank
05/04/21 Barclays
ZoomInfo price target raised to $59 from $57 at Barclays
04/22/21 Wolfe Research
ZoomInfo initiated with an Outperform at Wolfe Research
ZI ZoomInfo
$46.35 /

-0.1 (-0.22%)

  • 02
    Dec
  • 20
    Aug
ZI ZoomInfo
$46.35 /

-0.1 (-0.22%)

Upgrade
Toray Industries upgraded to Neutral from Sell at Goldman Sachs » 06:22
06/15/21
06/15
06:22
06/15/21
06:22
TRYIY

Toray Industries

$13.74 /

+0.02 (+0.15%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRYIY Toray Industries
$13.74 /

+0.02 (+0.15%)

11/25/20 Jefferies
Toray Industries upgraded to Hold from Underperform at Jefferies
07/17/20 Goldman Sachs
Toray Industries downgraded to Sell from Neutral at Goldman Sachs
06/16/20 Morgan Stanley
Toray Industries downgraded to Equal Weight from Overweight at Morgan Stanley
Hot Stocks
Cathie Wood's ARK Investment bought 21.1K shares of Unity Software on Monday  06:20
06/15/21
06/15
06:20
06/15/21
06:20
U

Unity Software

$102.29 /

+2.58 (+2.59%)

 
ShowHide Related Items >><<
U Unity Software
$102.29 /

+2.58 (+2.59%)

U Unity Software
$102.29 /

+2.58 (+2.59%)

05/14/21
Fly Intel: Top five analyst upgrades
05/14/21 Oppenheimer
Unity Software upgraded to Outperform from Perform at Oppenheimer
05/13/21 DA Davidson
Unity Software price target lowered to $150 from $175 at DA Davidson
05/12/21
Fly Intel: Top five analyst upgrades
U Unity Software
$102.29 /

+2.58 (+2.59%)

  • 08
    Feb
  • 18
    Sep
U Unity Software
$102.29 /

+2.58 (+2.59%)

U Unity Software
$102.29 /

+2.58 (+2.59%)

Recommendations
Prothena price target raised to $57 from $39 at Citi » 06:20
06/15/21
06/15
06:20
06/15/21
06:20
PRTA

Prothena

$47.67 /

+2.53 (+5.60%)

, BIIB

Biogen

$406.03 /

+9.57 (+2.41%)

Citi analyst Neena…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTA Prothena
$47.67 /

+2.53 (+5.60%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

PRTA Prothena
$47.67 /

+2.53 (+5.60%)

06/11/21 RBC Capital
Prothena price target raised to $50 from $28 at RBC Capital
06/10/21 H.C. Wainwright
Prothena price target raised to $58 from $33 at H.C. Wainwright
06/08/21 Oppenheimer
Prothena price target raised to $54 from $45 at Oppenheimer
06/08/21 Cantor Fitzgerald
Prothena price target raised to $62 from $43 at Cantor Fitzgerald
BIIB Biogen
$406.03 /

+9.57 (+2.41%)

06/14/21 Truist
Biogen price target raised to $647 from $458 at Truist
06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/14/21 Goldman Sachs
Biogen price target raised to $436 from $246 at Goldman Sachs
06/11/21
Fly Intel: Top five analyst upgrades
PRTA Prothena
$47.67 /

+2.53 (+5.60%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

  • 24
    Mar
BIIB Biogen
$406.03 /

+9.57 (+2.41%)

PRTA Prothena
$47.67 /

+2.53 (+5.60%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

Hot Stocks
Cathie Wood's ARK Investment discloses 211.5K shares of UiPath bought yesterday  06:18
06/15/21
06/15
06:18
06/15/21
06:18
PATH

UiPath

$69.93 /

-1.235 (-1.74%)

 
ShowHide Related Items >><<
PATH UiPath
$69.93 /

-1.235 (-1.74%)

PATH UiPath
$69.93 /

-1.235 (-1.74%)

06/09/21 BMO Capital
UiPath price target raised to $85 from $80 at BMO Capital
06/09/21 Canaccord
UiPath price target raised to $75 from $70 at Canaccord
06/09/21 Truist
UiPath price target raised to $82 from $80 at Truist
06/09/21 Morgan Stanley
UiPath growth 'impressive,' but factored into share price, says Morgan Stanley
PATH UiPath
$69.93 /

-1.235 (-1.74%)

  • 21
    Apr
PATH UiPath
$69.93 /

-1.235 (-1.74%)

PATH UiPath
$69.93 /

-1.235 (-1.74%)

Periodicals
Morgan Stanley CEO sends message for employees to return to office, FT reports » 06:18
06/15/21
06/15
06:18
06/15/21
06:18
MS

Morgan Stanley

$90.72 /

-1.32 (-1.43%)

Morgan Stanley CEO James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MS Morgan Stanley
$90.72 /

-1.32 (-1.43%)

MS Morgan Stanley
$90.72 /

-1.32 (-1.43%)

06/09/21 Jefferies
Jefferies starts 'compelling compounder' Morgan Stanley at Buy
06/09/21 Jefferies
Morgan Stanley initiated with a Buy at Jefferies
06/04/21 BofA
Morgan Stanley price target raised to $105 from $92 at BofA
06/01/21 Piper Sandler
Morgan Stanley price target raised to $93 from $87 at Piper Sandler
MS Morgan Stanley
$90.72 /

-1.32 (-1.43%)

MS Morgan Stanley
$90.72 /

-1.32 (-1.43%)

MS Morgan Stanley
$90.72 /

-1.32 (-1.43%)

MS Morgan Stanley
$90.72 /

-1.32 (-1.43%)

Hot Stocks
Ampio receives regulatory approval to expand AP-019 trial enrollment to India » 06:18
06/15/21
06/15
06:18
06/15/21
06:18
AMPE

Ampio

$1.81 /

+0.03 (+1.69%)

Ampio announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMPE Ampio
$1.81 /

+0.03 (+1.69%)

AMPE Ampio
$1.81 /

+0.03 (+1.69%)

AMPE Ampio
$1.81 /

+0.03 (+1.69%)

Initiation
Viatris initiated with a Neutral at Citi » 06:17
06/15/21
06/15
06:17
06/15/21
06:17
VTRS

Viatris

$15.61 /

-0.12 (-0.76%)

Citi analyst Navann Ty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VTRS Viatris
$15.61 /

-0.12 (-0.76%)

VTRS Viatris
$15.61 /

-0.12 (-0.76%)

04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
03/08/21
Fly Intel: Top five analyst downgrades
VTRS Viatris
$15.61 /

-0.12 (-0.76%)

VTRS Viatris
$15.61 /

-0.12 (-0.76%)

Hot Stocks
Cathie Wood's ARK Investment bought 183.2K shares of Etsy on Monday  06:17
06/15/21
06/15
06:17
06/15/21
06:17
ETSY

Etsy

$170.24 /

+4.49 (+2.71%)

 
ShowHide Related Items >><<
ETSY Etsy
$170.24 /

+4.49 (+2.71%)

ETSY Etsy
$170.24 /

+4.49 (+2.71%)

06/09/21 Jefferies
Etsy pullback creates 'compelling buying opportunity,' says Jefferies
06/07/21
Fly Intel: Top five analyst initiations
06/07/21 Atlantic Equities
Etsy initiated with an Overweight, $200 target at Atlantic Equities
06/07/21 Atlantic Equities
Etsy initiated with an Overweight at Atlantic Equities
ETSY Etsy
$170.24 /

+4.49 (+2.71%)

ETSY Etsy
$170.24 /

+4.49 (+2.71%)

ETSY Etsy
$170.24 /

+4.49 (+2.71%)

ETSY Etsy
$170.24 /

+4.49 (+2.71%)

Initiation
ITT initiated with a Buy at Citi » 06:16
06/15/21
06/15
06:16
06/15/21
06:16
ITT

ITT

$91.49 /

-1.4 (-1.51%)

Citi analyst Vladimir…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITT ITT
$91.49 /

-1.4 (-1.51%)

05/13/21 Gordon Haskett
Gordon Haskett downgrades ITT on valuation, high expectations
05/13/21 Gordon Haskett
ITT downgraded to Hold from Buy at Gordon Haskett
05/10/21 UBS
ITT downgraded to Neutral from Buy on valuation at UBS
05/10/21 UBS
ITT downgraded to Neutral from Buy at UBS
ITT ITT
$91.49 /

-1.4 (-1.51%)

Initiation
Triple Flag Precious Metals initiated with a Neutral at Credit Suisse » 06:14
06/15/21
06/15
06:14
06/15/21
06:14
TFPM.TO

Triple Flag Precious Metals

/

+

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Cocrystal Pharma price target lowered to $4 from $4.50 at H.C. Wainwright » 06:11
06/15/21
06/15
06:11
06/15/21
06:11
COCP

Cocrystal Pharma

$1.37 /

+0.125 (+10.08%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COCP Cocrystal Pharma
$1.37 /

+0.125 (+10.08%)

COCP Cocrystal Pharma
$1.37 /

+0.125 (+10.08%)

07/08/20
Fly Intel: Top five analyst initiations
07/08/20 H.C. Wainwright
Cocrystal Pharma initiated with a Buy at H.C. Wainwright
06/16/20 Noble Capital
Cocrystal Pharma initiated with an Outperform at Noble Capital
COCP Cocrystal Pharma
$1.37 /

+0.125 (+10.08%)

  • 27
    Aug
COCP Cocrystal Pharma
$1.37 /

+0.125 (+10.08%)

Hot Stocks
NanoString, Parker Institute for Cancer Immunotherapy enter collaboration » 06:11
06/15/21
06/15
06:11
06/15/21
06:11
NSTG

NanoString

$60.71 /

+1.43 (+2.41%)

NanoString Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSTG NanoString
$60.71 /

+1.43 (+2.41%)

NSTG NanoString
$60.71 /

+1.43 (+2.41%)

03/02/21 JPMorgan
NanoString price target raised to $80 from $75 at JPMorgan
03/02/21 Baird
NanoString price target raised to $78 from $70 at Baird
01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
NSTG NanoString
$60.71 /

+1.43 (+2.41%)

  • 08
    Oct
Hot Stocks
Radware and Involta announce partnership to deploy DDos Protection Service » 06:11
06/15/21
06/15
06:11
06/15/21
06:11
RDWR

Radware

$30.17 /

+0.2 (+0.67%)

Radware and Involta…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDWR Radware
$30.17 /

+0.2 (+0.67%)

RDWR Radware
$30.17 /

+0.2 (+0.67%)

02/11/21 Colliers
Radware downgraded to Neutral from Buy at Colliers
02/11/21 Barclays
Radware price target raised to $33 from $28 at Barclays
12/14/20 Monness Crespi
Radware initiated with a Neutral at Monness Crespi
RDWR Radware
$30.17 /

+0.2 (+0.67%)

  • 11
    Feb
Recommendations
Anavex price target raised to $25 from $17 at H.C. Wainwright » 06:10
06/15/21
06/15
06:10
06/15/21
06:10
AVXL

Anavex

$20.98 /

+5.49 (+35.44%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVXL Anavex
$20.98 /

+5.49 (+35.44%)

AVXL Anavex
$20.98 /

+5.49 (+35.44%)

02/24/21 Cantor Fitzgerald
Anavex price target raised to $25 from $10 at Cantor Fitzgerald
02/23/21 Cantor Fitzgerald
Anavex price target raised to $25 from $10 at Cantor Fitzgerald
12/29/20 Cantor Fitzgerald
Anavex cash position to fund operations into 2022, says Cantor Fitzgerald
12/16/20 H.C. Wainwright
Anavex price target raised to $17 from $14 at H.C. Wainwright
AVXL Anavex
$20.98 /

+5.49 (+35.44%)

AVXL Anavex
$20.98 /

+5.49 (+35.44%)

Hot Stocks
Stem and CleanCapital announce MOU to finance partnership » 06:10
06/15/21
06/15
06:10
06/15/21
06:10
STEM

Stem

$35.50 /

+2.28 (+6.86%)

Stem announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STEM Stem
$35.50 /

+2.28 (+6.86%)

STEM Stem
$35.50 /

+2.28 (+6.86%)

05/24/21
Fly Intel: Top five analyst initiations
05/24/21 Goldman Sachs
Stem initiated with a Buy at Goldman Sachs
STEM Stem
$35.50 /

+2.28 (+6.86%)

STEM Stem
$35.50 /

+2.28 (+6.86%)

General news
72% of fund managers believe inflation is transitory » 06:10
06/15/21
06/15
06:10
06/15/21
06:10
$ECON

Economic Data

/

+

72% of fund managers…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Hot Stocks
Biodesix announces availability of SARS CoV-2 neutralization antibody test » 06:09
06/15/21
06/15
06:09
06/15/21
06:09
BDSX

Biodesix

$16.15 /

+0.89 (+5.83%)

Biodesix announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDSX Biodesix
$16.15 /

+0.89 (+5.83%)

BDSX Biodesix
$16.15 /

+0.89 (+5.83%)

03/18/21 Morgan Stanley
Biodesix price target raised to $25 from $20 at Morgan Stanley
03/17/21 Canaccord
Biodesix a rare opportunity in precision oncology, says Canaccord
02/02/21 Canaccord
Biodesix price target raised to $31 from $27 at Canaccord
01/11/21 Canaccord
Biodesix price target raised to $27 from $26 at Canaccord
BDSX Biodesix
$16.15 /

+0.89 (+5.83%)

  • 28
    Oct
BDSX Biodesix
$16.15 /

+0.89 (+5.83%)

Syndicate
Ellington Residential 3.25M share Spot Secondary priced at $13.20 » 06:09
06/15/21
06/15
06:09
06/15/21
06:09
EARN

Ellington Residential

$13.76 /

+0.26 (+1.93%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EARN Ellington Residential
$13.76 /

+0.26 (+1.93%)

EARN Ellington Residential
$13.76 /

+0.26 (+1.93%)

11/23/20 BTIG
Ellington Residential initiated with a Buy at BTIG
EARN Ellington Residential
$13.76 /

+0.26 (+1.93%)

  • 15
    Jun
Earnings
Blucora raises FY21 non-GAAP EPS view to $1.50-$1.70 from $1.34-$1.60 » 06:08
06/15/21
06/15
06:08
06/15/21
06:08
BCOR

Blucora

$16.95 /

-0.01 (-0.06%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCOR Blucora
$16.95 /

-0.01 (-0.06%)

BCOR Blucora
$16.95 /

-0.01 (-0.06%)

04/01/21 JPMorgan
Blucora assumed with an Overweight at JPMorgan
02/17/21 Barrington
Blucora price target raised to $19 from $16 at Barrington
08/05/20 Barrington
Blucora price target lowered to $15 from $18 at Barrington
BCOR Blucora
$16.95 /

-0.01 (-0.06%)

Hot Stocks
Washington REIT to sell office portfolio to Brookfield fund for $766M » 06:07
06/15/21
06/15
06:07
06/15/21
06:07
WRE

Washington REIT

$26.84 /

-0.025 (-0.09%)

, BAM

Brookfield

$49.59 /

-0.02 (-0.04%)

WashREIT (WRE) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAM Brookfield
$49.59 /

-0.02 (-0.04%)

WRE Washington REIT
$26.84 /

-0.025 (-0.09%)

10/27/20 Wells Fargo
Raytheon office reduction negative for office REITs, says Wells Fargo
09/25/20
Fly Intel: Top analyst downgrades
09/25/20 Capital One
Washington REIT downgraded to Equalweight from Overweight at Capital One
07/02/20 JPMorgan
Washington REIT upgraded to Neutral on D.C. job market at JPMorgan
BAM Brookfield
$49.59 /

-0.02 (-0.04%)

04/09/21 Deutsche Bank
Brookfield price target raised to $45 from $43 at Deutsche Bank
04/01/21 Evercore ISI
Brookfield Property downgraded to In Line from Outperform at Evercore ISI
03/31/21
Fly Intel: Top five analyst downgrades
03/31/21 Credit Suisse
Brookfield downgraded to Neutral from Outperform at Credit Suisse
WRE Washington REIT
$26.84 /

-0.025 (-0.09%)

BAM Brookfield
$49.59 /

-0.02 (-0.04%)

BAM Brookfield
$49.59 /

-0.02 (-0.04%)

Syndicate
Alexandria Real Estate 7M share Spot Secondary priced at $184.00 » 06:07
06/15/21
06/15
06:07
06/15/21
06:07
ARE

Alexandria Real Estate

$193.40 /

-0.01 (-0.01%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARE Alexandria Real Estate
$193.40 /

-0.01 (-0.01%)

ARE Alexandria Real Estate
$193.40 /

-0.01 (-0.01%)

01/07/21 Baird
Alexandria Real Estate upgraded to Outperform from Neutral at Baird
10/16/20 UBS
Alexandria Real Estate initiated with a Neutral at UBS
10/02/20 Berenberg
Alexandria Real Estate initiated with a Buy at Berenberg
09/02/20 RBC Capital
Alexandria Real Estate price target raised to $184 from $175 at RBC Capital
ARE Alexandria Real Estate
$193.40 /

-0.01 (-0.01%)

  • 15
    Jun
  • 06
    Jan
  • 07
    Jul
ARE Alexandria Real Estate
$193.40 /

-0.01 (-0.01%)

Hot Stocks
AstraZeneca: Covid-19 vaccine effective against Delta variant » 06:07
06/15/21
06/15
06:07
06/15/21
06:07
AZN

AstraZeneca

$58.75 /

-0.02 (-0.03%)

New data from Public…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

Earnings
Blucora raises Q2 non-GAAP EPS view to $1.12-$1.21 from 94c-$1.11 » 06:06
06/15/21
06/15
06:06
06/15/21
06:06
BCOR

Blucora

$16.95 /

-0.01 (-0.06%)

Raises Q2 revenue view to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCOR Blucora
$16.95 /

-0.01 (-0.06%)

BCOR Blucora
$16.95 /

-0.01 (-0.06%)

04/01/21 JPMorgan
Blucora assumed with an Overweight at JPMorgan
02/17/21 Barrington
Blucora price target raised to $19 from $16 at Barrington
08/05/20 Barrington
Blucora price target lowered to $15 from $18 at Barrington
BCOR Blucora
$16.95 /

-0.01 (-0.06%)

Hot Stocks
AstraZeneca: Storm Chaser trial did not meet primary endpoint » 06:05
06/15/21
06/15
06:05
06/15/21
06:05
AZN

AstraZeneca

$58.75 /

-0.02 (-0.03%)

AstraZeneca announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.